Released, soluble GPVI ectodomain is a plasma biomarker of platelet activation and is elevated in patients with coronary artery disease, ischemic stroke, rheumatoid arthritis, inflammatory bowel disease, sepsis and trauma-induced coagulopathy [11,15,16,17]. The gene discussed is GP6; the disease is ischemic stroke.